Advertisement

Topics

Scilex grosses $140mm through senior secured note financing

15:40 EDT 13 Sep 2018 | Elsevier Business Intelligence

Sorrento Therapeutics Inc.'s Scilex Pharmaceuticals Inc. (patch technologies to deliver pain medications) sold institutional ...

Original Article: Scilex grosses $140mm through senior secured note financing

NEXT ARTICLE

More From BioPortfolio on "Scilex grosses $140mm through senior secured note financing"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...